Who are Solventum’s competitors?
Solventum names 25 companies as competitors in its latest annual report, on 4 fronts. 1 companies name Solventum back.
Skip to the field, head to head ↓Solventum company profile
Solventum keeps more of each dollar than most of its rivals, but grows less
Solventum names 25 competitors, spread across oral care, revenue cycle, wound care and a supplies segment. It is not fighting one rival. It is fighting a different crowd on each front, and the crowds differ in size and in appetite.
Put the numbers side by side. Solventum earned a 19% net margin on $8.3 billion of revenue. Of the rivals with figures here, only Microsoft at 40% and Oracle at 25% kept more. Cardinal Health kept 1%, Medline 4%, Becton Dickinson 8%. Growth tells the other half. Solventum grew 1%, while Medline grew 11%, Becton Dickinson 8% and Smith & Nephew 6%.
So the idea to repeat is this: Solventum is the profitable one in the room, not the fast one. Rivals are spending to widen their reach. Cardinal Health paid $1.2 billion for Specialty Networks and $1.1 billion for ADS. The margin shows Solventum's current positions are worth defending. The 1% growth leaves open whether they are enough.
Where Solventum says it competes
“Principal multinational competitors within the oral care market include Dentsply Sirona, Envista, and Straumann, all of which compete with both dental and orthodontic solutions, and Ivoclar, which competes with only dental solution offerings, and Align Technology, which competes with only orthodontic solution offerings.”
“Principal competitors include Optum, Microsoft (Nuance), Epic, Oracle (Cerner), Waystar, Athena, and a host of start-up technologies actively working to disrupt the areas of revenue cycle management and clinician productivity.”
“Our principal competitors in this segment include Becton Dickinson, Hartmann, ICU Medical, Medline, Cardinal Health, Fortive, Steris, MDF Instruments, and BSN.”
“the advanced wound care market is highly competitive, particularly in the United States and Europe, with our principal competitors including Smith & Nephew, Medaxis, Mölnlycke, Coloplast, and Convatec”
Who names Solventum as a competitor
“Solventum is a wound care company and key competitor that spun off from 3M in 2024, and Convatec is the only other UK-based MedTech company of scale.”
20-F for 2025The field, from the filings
| Company | Fiscal year | Revenue | Growth | Net margin | Employees |
|---|---|---|---|---|---|
| Solventum | 2025 | $8.3B | +1% | 19% | – |
| Microsoft | FY to Jun 2026 | $331.8B | +18% | 40% | 223,000 |
| Cardinal Health | FY to Jun 2026 | $254.2B | +14% | 1% | 63,900 |
| Oracle | FY to May 2026 | $67.4B | +17% | 25% | 141,000 |
| Medline | 2025 | $28.4B | +11% | 4% | 45,000 |
| Becton Dickinson | FY to Sep 2025 | $21.8B | +8% | 8% | – |
| Smith & Nephew | 2025 | $6.2B | +6% | 10% | – |
| Steris | FY to Mar 2026 | $5.9B | +9% | 13% | 18,000 |
| Fortive | 2025 | $4.2B | +2% | 14% | – |
| Align Technology | 2025 | $4.0B | +1% | 10% | 20,290 |
| Dentsply Sirona | 2025 | $3.7B | −3% | −16% | – |
Each company’s latest fiscal year as reported to the SEC, in US dollars; fiscal years end in different months. Rivals that report outside the US or in other currencies are not shown.
What the rivals have done lately
“On March 18, 2024, we completed the acquisition of Specialty Networks for a purchase price of $1.2 billion in cash, subject to certain adjustments.” filing
“On April 1, 2025, we completed the acquisition of ADS, a diabetic medical supplies provider to patients in the home, for a purchase price of $1.1 billion in cash, subject to certain adjustments.” filing
“We acquired certain companies and technologies during fiscal 2024 and 2023, including Cerner in fiscal 2023.” filing
“On September 3, 2024, BD completed the acquisition of Critical Care, which was renamed as BD Advanced Patient Monitoring.” filing
“On September 3, 2024, BD completed the acquisition of Edwards Lifesciences’ Critical Care product group, which was renamed as BD Advanced Patient Monitoring.” filing
“On 21 January 2026, we completed the acquisition of Integrity Orthopaedics, Inc, a US-based early stage commercial developer of Tendon Seam™, an innovative rotator cuff repair (RCR) system designed to significantly reduce re-tear rates a…” filing
Decisions that shaped the field
| Sony Won the Console War. Microsoft Decided to Stop Playing It. | 2024 | Too early to tell |
| Oracle Holds Customers With Three Layers: Architectural Debt, Licensing Fog, and the Audit | 2023 | Never undone |
Asked about Solventum’s competitors
Who are Solventum's competitors?
In its annual report for fiscal 2025, Solventum names 25 competitors across 4 fronts: multinational oral care competitors, principal competitors in healthcare revenue cycle, principal competitors in this segment and advanced wound care competitors. 10-K for fiscal 2025
Which companies name Solventum as a competitor?
1 companies in our coverage name it in their own annual reports: Smith & Nephew.
How does Solventum compare with its rivals?
Solventum reported $8.3B in revenue in its latest fiscal year, +1% on a year, with a 19% net margin. Microsoft: $331.8B, 40% net margin; Cardinal Health: $254.2B, 1% net margin.
What are the alternatives to Solventum?
The companies Solventum itself names as competitors are listed above, front by front, each in its own report’s words. Which matters for a given buyer depends on the job, not the list.
What would it actually cost a challenger to take your customer?
Sources: Solventum’s annual report for fiscal 2025; the annual reports of the companies that name it; each company’s financial data as reported to the SEC; Stratrix Decision Records. Analysis and data, not advice.
For information and strategic analysis only, not investment advice. Stratrix does not recommend buying, selling or holding any security.
Tools to try
- Ansoff move finderFramework: Ansoff Matrix
- Business model canvas builderFramework: Business Model Canvas
- Change readiness checkFramework: Kotter's 8-Step Change Model
- Five Forces scorerFramework: Porter's Five Forces
- SMART goal builderFramework: SMART Goals
- SWOT builderFramework: SWOT Analysis
More from Stratrix
The Moat Anatomy Casebook
Every verified case of this decision, with what was on the table and how it turned out, in Excel, PowerPoint, Word and PDF.
35 verified cases · $299See the casebook →The Business Model Wizard
Make the seven choices that define your model, test your numbers against real companies, and meet the rival AI would build against you.
Free · about twelve minutesBuild your Model Thesis →Stratrix Team
Every Casebook, three Strategy Packs a seat each year and Ask Stratrix, for teams that face these decisions all year.
$1,999 a year · $499 a seatWhat is included →New analyses, by email
The defining moves in business, and what they teach, as they publish.